Beyond Meat Class Action Seeks Investors Over Asset Impairment Allegations

BenzingaBenzinga
|||1 min read
Key Takeaway

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.

Beyond Meat Class Action Seeks Investors Over Asset Impairment Allegations

The Schall Law Firm is soliciting Beyond Meat, Inc. shareholders who purchased securities during a nine-month period to participate in pending securities litigation. The class action targets purchases made between February 27 and November 11, 2025, alleging the company issued materially misleading statements regarding its long-lived asset valuations.

According to the complaint, Beyond Meat failed to disclose that certain assets on its balance sheet would require substantial non-cash impairment charges, a significant accounting adjustment that impacts reported earnings and shareholder equity. The alleged misstatements would have been material to investment decisions during the specified period. Investors seeking to join the litigation must submit their claims by March 24, 2026.

Securities class actions involving accounting disclosures typically require plaintiffs to demonstrate that investors relied on the alleged misstatements when making purchase decisions. The Schall Law Firm is handling case administration and will work to establish the scope of eligible shareholders and potential damages.

Source: Benzinga

Back to newsPublished Feb 13

Related Coverage

GlobeNewswire Inc.

Plug Power Faces Class Action Over DOE Loan Claims as April Deadline Looms

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

PLUG
GlobeNewswire Inc.

BlackRock TCP Capital Hit by Class Action Over $19B NAV Collapse

BlackRock TCP Capital faces class action lawsuit after 19% NAV decline and 12.97% stock plunge. Investors must act by April 6 deadline.

TCPC
GlobeNewswire Inc.

Corcept Therapeutics Faces Class Action Over FDA Rejection; Stock Crashed 50%

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

CORT
GlobeNewswire Inc.

Class Action Lawsuit Filed Against China Liberal Education Over Alleged $300M Pump-and-Dump Scheme

Class action lawsuit filed against China Liberal Education Holdings for alleged pump-and-dump scheme coordinating with scammers, resulting in $300M+ investor losses.

CLEUF
GlobeNewswire Inc.

METC Faces Class Action Over Brook Mine Claims; Lead Plaintiff Deadline Set for March 31

Ramaco Resources faces class action lawsuit over alleged false Brook Mine operational claims, with lead plaintiff deadline set for March 31, 2026.

METCMETCBMETCI
GlobeNewswire Inc.

Disc Medicine Stock Collapses on FDA Rejection; Law Firm Probes Securities Fraud

Pomerantz LLP investigates Disc Medicine ($IRON) for potential securities fraud after FDA rejected bitopertin drug application, triggering consecutive stock declines totaling over 28%.

IRON